ACC CardiaCast: What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten
ACC CardiaCast - Un pódcast de American College of Cardiology - Viernes
In this episode, Drs. Matt Martinez and Theodore Abraham discuss “What the Clinician Should Know About the Cardiac Myosin Inhibitor Mavacamten” for the treatment of hypertrophic cardiomyopathy, and its mechanisms of action.
